Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2596-2602, November 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Omine, M.
Right arrow Articles by Perry, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omine, M.
Right arrow Articles by Perry, S.

Perturbation of Leukemic Cell Population in AKR Mice Due to Chemotherapy1

Mitsuhiro Omine2 and Seymour Perry3

Division of Cancer Treatment, National Cancer Institute, NIH, Bethesda, Maryland 20014

The perturbation within the leukemic cell population due to effective chemotherapy has been analyzed in spontaneous AKR leukemia with cell sedimentation at 1 x g for the cytokinetic characterization. AKR mice with advanced leukemia were treated with 150 mg 1-ß-D-arabinofuranosylcytosine per kg (depot form of arabinosylcytosine) i.p. once a day for up to 3 days and were sacrificed on the day following the last injection. The thymus weight and the surviving cell number were reduced rapidly in an apparently exponential fashion. Successful treatment was accompanied by a marked and consistent alteration in cell size distribution. Medium and large cells were preferentially eliminated from the entire population, but a significant number of the small cells appear to have survived. These small cells, as well as the larger cells, were still capable of inducing leukemia after 1 and 2 days of treatment. However, after 3 days of treatment, this capability was lost. It was concluded that the small cells are heterogeneous as to clonogenicity, i.e., they consist of both nonclonogenic and clonogenic cells residing in either a G0 or a long G1 phase of the cell cycle.

1 Presented in part at the Annual Meeting of the American Society of Hematology, Hollywood, Fla., December 3 to 6, 1972.

2 Present address: The Third Department of Internal Medicine, University of Tokyo, Hongo, Bunkyo-Ku, Tokyo, Japan.

3 To whom correspondence should be addressed.

Received 3/21/73. Accepted 7/11/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.